In partnership with

Welcome to the iPrompt Newsletter
Friday Edition

What you get in the Friday Edition

  1. Weekly Scoreboard

  2. Top Headlines of the Week

  3. Our Investing Angle

  4. Three Ideas to Research This Weekend

  5. AI Investment Framework

  6. Your Move


…all in a FREE Weekly newsletter.

Accio Work: Your Business, On Autopilot

Meet Accio Work, the agentic workspace designed to run your business operations end to end. From sourcing products and negotiating with suppliers to managing your store and launching marketing campaigns, Accio Work handles the execution so you don’t have to.

Powered by verified capabilities and deep integrations with business tools, it doesn’t just generate ideas, it takes action. Backed by Alibaba.com’s global supplier network and over 1B products, it seamlessly connects strategy to execution.

Stay in control while everything runs on autopilot.

iPrompt Signals

AI & robotics investing — explained so you can actually act on it.

The Hook

TSMC raised its 2026 guide past 30% growth. The stock ran. ASML raised its own guide to €36–40B and sold off 4% on a single China headline. Same week. Same demand signal. Opposite tape. One of those trades is mispriced. The order book says which.

Weekly Scoreboard

Ticker

Thu close

Week %

What happened

SPX

7,041.28

+3.3%

Record close Wednesday, slight pullback Thursday

NVDA

$198.53

+0.4%

Geopolitics keeping a lid on despite TSMC read-through

TSM

$324.18

+5.4%

Q1 profit +58%, 2026 guidance raised to >30% growth

AVGO

$398.47

+4.1%

Up 9 of last 10 sessions — custom silicon ramp story

ASML

$891.40

-4.2%

Beat numbers, guidance raised, stock sank on China fears

MU

$457.23

+2.3%

Memory cycle intact; HBM demand pulling ahead

SMH

$452.00

+2.8%

YTD +25.5%, powered by equipment and memory names

BOTZ

$37.87

+0.5%

Digesting Figure’s $1B round, no immediate catalyst

VIX

17.94

-8.6%

Near 52-week low (range 13–36). Calm, verging on complacent

VIX = the “fear gauge.” Measures expected S&P 500 swings over the next 30 days. Under 18 = markets are sleeping. Above 25 = real anxiety.

Bottom line: Records, low VIX, narrow leadership. The tape is priced for things to keep going right.

The Two Numbers That Mattered

1. TSMC smashes Q1, raises 2026 guidance to +30%

Taiwan Semiconductor posted $35.9B in Q1 revenue, a 58% jump in profit, and a gross margin of 66.2%. Advanced chips — sub-7nm — now account for 75% of wafer revenue, up meaningfully from a year ago. Management guided 2026 full-year growth to north of 30% in US-dollar terms and Q2 revenue to $39–40B.

The read-through: demand isn’t peaking on this print. It’s running harder into the back half of 2026, and the marginal wafer needs equipment TSMC doesn’t make itself.

2. ASML beats, guides up, stock sinks on China

ASML reported €8.8B in Q1 revenue, €2.8B in net income, and raised 2026 guidance to €36–40B (up from previous). Gross margin landed at 53%, the top of the range. Then the stock dropped 4% on the day, on fresh concerns that US export controls could further restrict sales into China.

This is the contrarian story of the week: the supplier every 7nm-and-below AI chip in commercial production depends on beat, raised, and got punished for it.

Our Investing Angle

Everyone’s watching the record close. The smarter bet is reading ASML’s order book.

The thesis: The AI trade has moved one layer down. The demand-side winners — NVIDIA, the hyperscalers, the model companies — still work. But this week’s order books say the next leg of margin sits in the companies that sell the tools that build the chips.

What the two prints imply in combination: TSMC’s leading-node mix is already three-quarters of revenue, and ASML’s book now stretches 18 months forward at peak margin. The chips are clearing; the tools to make the next round of chips are sold out. Demand for the chip and demand for the tool have decoupled on timing — the tool side is locked further out, and its margin shows up earlier in the cycle when fabs race to expand. That asymmetry is what gets re-rated when the capex debate resolves. It’s not in this tape yet.

The equipment layer got paid twice this week and re-rated down. That’s where we think the mispricing sits. The honest disconfirmation: if a single hyperscaler guides 2026 capex down at Q2 earnings, this thesis stalls within two quarters. Microsoft on 29 April is the first test.

⚠ What Could Go Wrong? (The Bear Case)

China retaliation. Beijing restricting rare earths or photoresist chemicals compresses equipment margins fast.

Supply catches up. Samsung or Intel Foundry hitting leading-node yields by H2 2026 normalises TSMC pricing — and equipment orders with it.

Size for the possibility that the thesis takes longer than expected.

Two Ideas to Research This Weekend

Not recommendations — starting points for your own research.

1. ASML — The near-monopoly on the leading-edge tool

Why now 2026 guide raised to €36–40B. 18-month order book. Stock fell 4% this week on China fear despite a clean beat.

The case Near-monopoly on EUV lithography — every 7nm-and-below chip in commercial production runs through an ASML machine. And the moat deepens: High-NA EUV (the $400M-per-tool machine for 2nm and below) is currently single-sourced.

The risk If the US tightens equipment export controls further (Ricketts-Kim bill introduced April 2), ASML’s China line takes a direct hit.

Tripwire Q2 earnings on 16 July — if China revenue drops below 15% and Q3 guide still raises, thesis strengthens. If China stays above 20%, the geopolitical overhang gets worse.

How to research ASML (ADR) or SMH (VanEck Semiconductor ETF).

2. Tokyo Electron — same thesis, Japan pricing

The steps between ASML’s lithography passes — etch, deposition, coater/developer — sit with Tokyo Electron (8035.T). It trades at a noticeable discount to AMAT and LRCX, and its order book rides the same TSMC/Samsung capex we just discussed. Weak yen is a tailwind on a 70%+ export book; the offset is ~25% China exposure, higher than ASML’s, so tighter Japan export controls would hit it harder. Tripwire: Japan’s May machine-tool orders report (mid-June) flat or negative MoM would weaken the domestic tailwind. Research: 8035.T or EWJ (iShares MSCI Japan, ~2% weight).

Framework Snapshot — No Changes This Week

Six layers. Conviction, risk and sizing at a glance. Per-layer ticker detail lives in the companion deep dive.

Infrastructure stays HIGH. TSMC’s advanced-node mix and ASML’s 18-month book are the two hardest data points in the hyperscaler-capex debate — neither moved against the thesis this week, so neither moves the conviction.

What We’re Watching — Upcoming Catalysts

Date

Event

Question to track

29 Apr 2026

Microsoft Q3 earnings

Azure AI revenue line item — still 3x hyperscale growth?

4 May 2026

Palantir Q1 earnings

US commercial revenue YoY and AIP operating margin

16 Jul 2026

ASML Q2 earnings

China revenue %, Q3 guide

Disclaimer: This newsletter is for informational and educational purposes only and does not constitute financial advice. iPrompt Signals is not a registered investment advisor. Always conduct your own research and consult a qualified financial professional before making investment decisions.

Your Move

One action for the weekend.

Pick a semi-equipment name — ASML, AMAT, LRCX, or Tokyo Electron — and read their most recent 10-Q. Look for one number: 2026 order book versus 2024 order book. That single comparison tells you whether the thesis is real or narrative. Everything else in this issue points at the same decision — this is the one step that makes it yours.

The companion deep dive has the full equipment-layer map, per-layer ticker detail and YTD chart if you want to go wider before Monday.

Stay curious — and stay qualified.

— R. Lauritsen

FrontWave Media Ltd · Not financial advice. Research starting points only.

Accio Work: Your Business, On Autopilot

Run your business effortlessly with Accio Work. Our specialized AI agents handle sourcing, supplier deals, store management, and marketing—all automatically. Backed by Alibaba.com’s vast product network, execution is fast and reliable. Skip the complexity—get results instantly while staying in full control of your growth.

Recommended for you